Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Consolidated Net IncomeEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Gross ProfitIncome from Continuing OperationsIncome towards Parent CompanyInterest & Investment IncomeNet Income towards Common StockholdersNon Operating IncomeOperating ExpensesOperating IncomeOther Non Operating IncomeProfit After TaxResearch & DevelopmentRevenueSelling, General & AdministrativeShares Outstanding (Diluted Average)Shares Outstanding (Weighted Average)Tax Provisions
Others
Ratios

Centessa Pharmaceuticals (CNTA) Research & Development: 2019-2024

Historic Research & Development for Centessa Pharmaceuticals (CNTA) over the last 6 years, with Dec 2024 value amounting to $150.2 million.

  • Centessa Pharmaceuticals' Research & Development rose 22.59% to $41.6 million in Q3 2025 from the same period last year, while for Sep 2025 it was $178.6 million, marking a year-over-year increase of 49.99%. This contributed to the annual value of $150.2 million for FY2024, which is 20.77% up from last year.
  • Latest data reveals that Centessa Pharmaceuticals reported Research & Development of $150.2 million as of FY2024, which was up 20.77% from $124.4 million recorded in FY2023.
  • In the past 5 years, Centessa Pharmaceuticals' Research & Development ranged from a high of $155.1 million in FY2022 and a low of $9.3 million during FY2020.
  • Moreover, its 3-year median value for Research & Development was $150.2 million (2024), whereas its average is $143.2 million.
  • Per our database at Business Quant, Centessa Pharmaceuticals' Research & Development surged by 928.49% in 2021 and then dropped by 19.78% in 2023.
  • Yearly analysis of 5 years shows Centessa Pharmaceuticals' Research & Development stood at $9.3 million in 2020, then surged by 928.49% to $95.7 million in 2021, then spiked by 62.12% to $155.1 million in 2022, then dropped by 19.78% to $124.4 million in 2023, then increased by 20.77% to $150.2 million in 2024.